Article: HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients.

Article: One millionth Taxus Express Coronary Stent system ...
Advanced Materials & Processes;  April 1, 2005 ;     642 words ...Boston Scientific Corporation, Natick, Mass., has announced the implantation of its millionth Taxus Express paclitaxel-eluting coronary stent system, marking a major milestone for the company and for the treatment of coronary artery ...

Article: FDA approval for Taxus Express stent.(Brief ...
Pharma Marketletter;  March 15, 2004 ;     568 words ...The US Food and Drug Administration has approved Boston Scientific's Taxus Express paclitaxel-eluting coronary stent system, which is licensed from its developer, Angiotech Pharmaceuticals. Boston's chief ...

Article: FRENCH GOVERNMENT EXPANDS REIMBURSEMENT FOR TAXUS ...
Biotech Equipment Update;  January 1, 2005 ;     699 words ... ... mm in length) and lesions located in the proximal left anterior descending artery. Reimbursement was also approved for TAXUS Express(2) stents with a diameter of 4mm. At the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C ...

Article: Enrollment complete in SYNTAX trial for Taxus ...
Medical Device Daily;  April 27, 2007 ;     508 words ...Enrollment complete in SYNTAX trial for Taxus Express 2 stent A Medical Device Daily Staff Report Boston Scientific (Natick, Massachusetts) reported completion of enrollment in its ...

Article: Boston Scientific Welcomes Publication of HORIZONS ...
PR Newswire;  May 6, 2009 ;     700+ words ... ... 000 patients enrolled worldwide, HORIZONS AMI is the largest randomized trial ... year results demonstrated that the TAXUS Express Stent significantly reduced angiographic ... thrombosis at one year. "The HORIZONS AMI trial provided outcomes data showing ...

Article: New Analysis From HORIZONS-AMI Shows Major Bleeding ...
Business Wire;  September 3, 2008 ;     700+ words ... ... presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding ... Germany. "The new analysis from HORIZONS-AMI reveals that major bleeding is an important ... showed improved 30-day survival in the HORIZONS-AMI study. While re-infarction resulted ...

Article: The Medicines Company Announces HORIZONS-AMI 1-Year ...
Business Wire;  October 14, 2008 ;     700+ words ... ... that 1-year clinical data from the HORIZONS-AMI trial, comparing Angiomax[R] (bivalirudin ... following late-breaking clinical trial: HORIZONS AMI: A Prospective Randomized Trial of ... email at jromero@crf.org. About the HORIZONS-AMI Trial HORIZONS-AMI, co-funded by ...